Efranat Ltd.
🇮🇱Israel
Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Phase 1
- Conditions
- Recurrent Respiratory Papillomatosis
- Interventions
- First Posted Date
- 2016-08-03
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Efranat Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT02854761
Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumors
- Interventions
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Efranat Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02052492
- Locations
- 🇮🇱
Rambam MC, Haifa, Israel
🇮🇱Sheba Medical Center, Ramat-Gan, Israel
News
No news found